期刊論文| 1. | North American Association for the Study of Obesity、American Diabetes Association、American Association of Clinical Endocrinologists、American Psychiatric Association(2004)。Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes。The Journal of Clinical Psychiatry，65(2)，267-272。   |
| 2. | American Diabetes Association、American Psychiatric Association、American Association of Clinical Endocrinologists、North American Association for the Study of Obesity(2004)。Consensus development conference on antipsychotic drugs and obesity and diabetes。Diabetes Care，27(2)，596-601。 |
| 3. | 張文和(20051200)。精神分裂症治療之選藥原則。臺灣精神醫學，19(4)，264-282。 延伸查詢 |
| 4. | Stroup, T. S.、Lieberman, J. A.、McEvoy, J. P.(2006)。Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic。American Journal of Psychiatry，163(4)，611-622。 |
| 5. | Möller, H. J.(2005)。Are the new antipsychotics no better than the classical neuroleptics?。European Archives of Psychiatry and Clinical Neuroscience，255(6)，371-372。 |
| 6. | Freedman, R.(2005)。The choice of antipsychotic drugs for schizophrenia。New England Journal of Medicine，353(12)，1286-1288。 |
| 7. | Ramaswamy, S.、Vijay, D.、William, M.、Sattar, S. P.、Praveen, F.、Petty, F.(2004)。Aripiprazole possibly worsens psychosis。International Clinical Psychopharmacology，19(1)，45-48。 |
| 8. | Lieberman, J. A.、Stroup, T. S.、McEvoy, J. P.、Swartz, M. S.、Rosenheck, R. A.、Perkins, D. O.、Hsiao, J. K.(2005)。Effectiveness of antipsychotic drugs in patients with chronic schizophrenia。New England Journal of Medicine，353(12)，1209-1223。 |
| 9. | Sartorius, N.、Fleischhacker, W. W.、Gjerris, A.(2003)。The usefulness and use of second-generation antipsychotic medications: an update of the review of evidence and recommendations by a Task Force of the World Psychiatric Association。Current Opinion in Psychiatry，16(S1)，1-44。 |